AnalystsRobert DriscollRobert Driscoll's Stock Forecasts
AnalystsRobert Driscoll
Sectors:
Industries:
Analyst Ranking
Top 11%
#538 out of 5279 analysts
Average Return
+10.56%
Win Rate
39%78 out of 198
Risk vs Reward
Poor
Good
Robert Driscoll's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Janux Therapeutics IncJANX | +718.88% | $6.62 | $54.21 | 2023-11-08 - 2024-11-07 | Buy |
Five Prime Therapeutics IncFPRX | +494.68% | $6.39 | $38.00 | 2020-06-22 - 2021-04-15 | Buy |
Alpine Immune Sciences IncALPN | +414.33% | $12.63 | $64.96 | 2023-11-15 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +403.57% | $12.90 | $64.96 | 2023-09-01 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +381.19% | $13.50 | $64.96 | 2023-08-15 - 2024-05-16 | Buy |
Robert Driscoll Analyst Color
Get additional color on Robert Driscoll's coverage of popular stocks
Robert Driscoll's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | 6 | Buy | $33.00 | +63.04% | Maintains | 10 days ago |
Aprea Therapeutics IncAPRE | 6 | Buy | $6.00 | +531.58% | Maintains | 10 days ago |
Avalo Therapeutics IncAVTX | 2 | Buy | $34.00 | +107.95% | Maintains | 10 days ago |
Eikon Therapeutics IncEIKN | 3 | Sell | $5.00 | -54.17% | Maintains | 12 days ago |
Janux Therapeutics IncJANX | 8 | Buy | $36.00 | +147.93% | Maintains | 16 days ago |
Cullinan Therapeutics IncCGEM | 7 | Buy | $37.00 | +167.34% | Maintains | 16 days ago |
Revolution Medicines IncRVMD | 11 | Buy | $165.00 | +8.87% | Maintains | 17 days ago |
Pyxis Oncology IncPYXS | 1 | Buy | $6.00 | +206.12% | Initiates Coverage On | 19 days ago |
Ideaya Biosciences IncIDYA | 12 | Buy | $58.00 | +99.31% | Maintains | a month ago |
Replimune Group IncREPL | 8 | Hold | $2.00 | -59.27% | Downgrades | a month ago |
Arcus Biosciences IncRCUS | 8 | Buy | $41.00 | +74.99% | Maintains | 2 months ago |
Black Diamond Therapeutics IncBDTX | 10 | Buy | $14.00 | +514.04% | Maintains | 2 months ago |
Cytomx Therapeutics IncCTMX | 7 | Buy | $11.00 | +192.55% | Maintains | 2 months ago |
Foghorn Therapeutics IncFHTX | 6 | Buy | $10.00 | +136.97% | Reiterates | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 8 | Hold | $21.50 | -0.14% | Downgrades | 3 months ago |
Kura Oncology IncKURA | 11 | Buy | $36.00 | +220.00% | Maintains | 3 months ago |
Arvinas IncARVN | 8 | Hold | $11.00 | +21.01% | Maintains | 3 months ago |
Tyra Biosciences IncTYRA | 10 | Buy | $53.00 | +63.23% | Maintains | 3 months ago |
Cg Oncology IncCGON | 1 | Buy | $70.00 | +8.95% | Initiates Coverage On | 5 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Buy | $38.00 | +234.80% | Maintains | 7 months ago |
Crescent Biopharma IncCBIO | 1 | Buy | $27.00 | +30.18% | Initiates Coverage On | 10 months ago |
Zentalis Pharmaceuticals IncZNTL | 11 | Hold | $4.00 | N/A | Reiterates | a year ago |
Werewolf Therapeutics IncHOWL | 3 | Buy | $6.00 | N/A | Maintains | a year ago |
Monte Rosa Therapeutics IncGLUE | 4 | Buy | $17.00 | N/A | Maintains | a year ago |
Igm Biosciences IncIGMS | 9 | Buy | $22.00 | N/A | Maintains | 2 years ago |
Adicet Bio IncACET | 8 | Buy | $80.00 | N/A | Reiterates | 2 years ago |
Omega Therapeutics IncOMGAQ | 4 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Geron CorpGERN | 8 | Buy | $7.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 7 | Hold | $65.00 | N/A | Reiterates | 2 years ago |
Elevation Oncology IncELEV | 7 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Atreca IncBCEL | 4 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Cyteir Therapeutics IncCYTT | 3 | Buy | $3.00 | N/A | Reiterates | 3 years ago |
Surface Oncology IncSURF | 1 | Buy | $3.00 | N/A | Reiterates | 3 years ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 4 years ago |
Harpoon Therapeutics IncHARP | 3 | Buy | $70.00 | N/A | Upgrades | 4 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | $1.80 | N/A | Downgrades | 4 years ago |
Aceragen IncACGN | 2 | Hold | $1.00 | N/A | Downgrades | 5 years ago |
Five Prime Therapeutics IncFPRX | 4 | Buy | $9.00 | N/A | Upgrades | 6 years ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | N/A | Upgrades | 6 years ago |
Nabriva Therapeutics PLCNBRVF | 1 | Hold | $250.00 | N/A | Downgrades | 6 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $34.00 | N/A | Reiterates | 9 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $4.00 | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.